NFL BiosciencesFRA:82F -0.13%28 PB Ratio is 32.58 as of Jul. 05, 2026. GuruFocus rates FRA:82F with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,230 Biotechnology companies, NFL Biosciences ranks worse than 95.93% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-05), NFL Biosciences's share price is €0.782. NFL Biosciences's Book Value per Share for the quarter that ended in Dec. 2025 was €0.02. Hence, NFL Biosciences's PB Ratio of today is 32.58.
The historical rank and industry rank for NFL Biosciences's PB Ratio or its related term are showing as below:
FRA:82F'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 35.71
Current: 35.71
During the past 8 years, NFL Biosciences's highest PB Ratio was 35.71. The lowest was 0.00. And the median was 0.00.
FRA:82F's PB Ratio is ranked worse than 95.93% of 1230
companies
in the Biotechnology industry
Industry Median: 2.98
vs FRA:82F: 35.71
During the past 12 months, NFL Biosciences's average Book Value Per Share Growth Rate was -75.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -47.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -20.00% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of NFL Biosciences was 247.20% per year. The lowest was -47.00% per year. And the median was 14.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
NFL Biosciences PB Ratio Related Terms
NFL Biosciences PB Ratio Historical Data
* Premium members only.
The historical data trend for NFL Biosciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, NFL Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NFL Biosciences PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NFL Biosciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where NFL Biosciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
NFL Biosciences's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
NFL Biosciences (FRA:82F) has a PB Ratio of 32.58 as of Jul. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NFL Biosciences and its competitors. According to the industry distribution chart, NFL Biosciences ranks #1180 out of 1230 companies in the Biotechnology industry, placing it in the top 95.9%.
Is NFL Biosciences' PB Ratio too high?
NFL Biosciences' current PB Ratio is 32.58. The Biotechnology industry median PB Ratio is 2.98. NFL Biosciences' value of 32.58 is 993.3% above this industry median. Based on the distribution chart, NFL Biosciences ranks #1180 out of 1230 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NFL Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does NFL Biosciences' PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NFL Biosciences ranks #1180 out of 1230 companies for PB Ratio. This places NFL Biosciences in the lower half of its industry. The industry median PB Ratio is 2.98. NFL Biosciences' value of 32.58 is 993.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.98, based on 1,230 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NFL Biosciences's current PB Ratio of 32.58 is 993.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NFL Biosciences and its competitors. For the Biotechnology industry, the median PB Ratio is 2.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NFL Biosciences's current PB Ratio is 32.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NFL Biosciences stock overvalued right now?
NFL Biosciences (FRA:82F) has a current PB Ratio of 32.58. The current PB Ratio is 32.58 and 993.3% above the Biotechnology industry median of 2.98. NFL Biosciences' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For NFL Biosciences (FRA:82F), the current PB Ratio is 32.58 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
28GF Score
Get the complete analysis for FRA:82F
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:82F has been successfully added to your 
